You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

CLINICAL TRIALS PROFILE FOR INGENOL MEBUTATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Ingenol Mebutate

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00742391 ↗	A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations	Completed	Peplin	Phase 3	2008-09-01	The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.
NCT00850681 ↗	A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers	Completed	Peplin	Phase 1	2009-02-01	This Phase 1 study is designed to determine the photoallergic potential of PEP005 Gel, 0.01% and it's vehicle on normal skin.
NCT00850811 ↗	A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers	Completed	Peplin	Phase 1	2009-02-01	This Phase 1 study is designed to determine the photoirritation potential of PEP005 Gel, 0.01% when application is followed by light exposure.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Ingenol Mebutate

Condition Name

Chart
Table

Condition Name for Ingenol Mebutate
Intervention	Trials
Actinic Keratosis	33
Actinic Keratoses	5
Actinic Cheilitis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Ingenol Mebutate
Intervention	Trials
Keratosis	42
Keratosis, Actinic	42
Carcinoma, Basal Cell	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Ingenol Mebutate

Trials by Country

Map
Table

Trials by Country for Ingenol Mebutate
Location	Trials
United States	100
Australia	20
United Kingdom	15
Canada	8
Germany	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Ingenol Mebutate
Location	Trials
California	9
New York	8
Indiana	8
Texas	7
Florida	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Ingenol Mebutate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Ingenol Mebutate
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	11
Phase 2	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Ingenol Mebutate
Clinical Trial Phase	Trials
Completed	42
Unknown status	4
Withdrawn	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ingenol Mebutate

Sponsor Name

Chart
Table

Sponsor Name for Ingenol Mebutate
Sponsor	Trials
LEO Pharma	27
Peplin	12
Icahn School of Medicine at Mount Sinai	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Ingenol Mebutate
Sponsor	Trials
Industry	42
Other	29
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.